DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13738
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSinghvi, Gautam-
dc.date.accessioned2024-01-09T07:00:12Z-
dc.date.available2024-01-09T07:00:12Z-
dc.date.issued2022-12-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0144861722009195-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13738-
dc.description.abstractOcular drug delivery is a significantly challenging task due to the presence of various anatomical and physiological barriers in the eye. Naturally available polysaccharides, when used as drug vehicles provide increased retention time, bioavailability, and penetration due to their unique mucoadhesive and charge-possessing nature. This review discusses the polysaccharide-based drug delivery system for the eye. Polysaccharides like alginic acid, cellulose derivatives, chitosan, pectin, xanthan gum, gellan gum, and hyaluronic acid are reviewed in this report. Additionally, emphasis is given to some of the recently investigated polymers such as sugarcane bagasse cellulose, a polysaccharide extracted from the seeds of Manilkara zapota, and Tremella fuciformis polysaccharide as drug vehicles for effective ocular drug delivery. This review also provides insight on clinical status and FDA-approved polysaccharides for ophthalmic delivery of therapeutics.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectIn-situ gelling systemsen_US
dc.subjectNanoparticlesen_US
dc.subjectOcular drug deliveryen_US
dc.subjectPolysaccharideen_US
dc.subjectSugarcane bagasse celluloseen_US
dc.titleInsight on updates in polysaccharides for ocular drug deliveryen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.